JEADV Clinical Practice (Jun 2023)

Deucravacitinib, a TYK2 inhibitor, safety in psoriasis and psoriatic arthritis: What should a dermatologist know?

  • Inês Pereira Amaral,
  • Joana Antunes,
  • Ivânia Soares,
  • Madalena Pupo Correia,
  • Paulo Filipe

DOI
https://doi.org/10.1002/jvc2.132
Journal volume & issue
Vol. 2, no. 2
pp. 382 – 385

Abstract

Read online

No abstracts available.